Skip to main content
VCbacked
Log inGet Started

Star Therapeutics

South San Francisco, United States

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

$125.0M raised
Sep 2025
Series D
Health CareMedicalTherapeutics

Top Investors

OrbiMedBlue OwlRA Capital ManagementCormorant Asset ManagementCatalio Capital Management

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Star Therapeutics

How much funding has Star Therapeutics raised?
Star Therapeutics has raised $125.0M in total funding. The most recent round was Series D. The last funding was announced in September 2025.
Who are Star Therapeutics's investors?
Star Therapeutics's investors include OrbiMed, Blue Owl, RA Capital Management, Cormorant Asset Management, Catalio Capital Management.
Where is Star Therapeutics headquartered?
Star Therapeutics is headquartered in South San Francisco, United States.
What does Star Therapeutics do?
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
What stage is Star Therapeutics at?
Star Therapeutics is at the Series D stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Star Therapeutics — Funding & Investors." VCBacked, September 30, 2025, https://www.vcbacked.co/company/star-therapeutics. Accessed June 3, 2026.
APA
VCBacked. (2025). Star Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/star-therapeutics
Wikipedia (cite web)
{{cite web |title=Star Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/star-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K